ACNU Feasibility

View full report
GoodMucinex D is an OTC extended-release oral tablet with manageable side effects and moderate misuse risk due to pseudoephedrine. It requires caution in special populations, has simple dosing, minimal monitoring, but some drug interactions and adherence challenges.

ACNU Feasibility Scorecard

Chart with 11 data points.
Mucinex D
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying ← Lower is Better!. Data ranges from 1 to 5.
End of interactive chart.